MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/14/2026, 02:12 PM (Berlin time), refresh in progress.

Cellebrite DI Stock

Cellebrite DI Ltd.

CLBTNASDAQMarkt
US$11.03
-3.1% today

Company data

Sector
Technology
Industry
Software - Infrastructure
Country
Israel
CEO
Shiv Ramji
Employees
1,285
Market cap
$2.8 B
IPO
06/11/2020

Cellebrite DI Ltd. is a technology company operating in the software, infrastructure industry that delivers specialized digital intelligence solutions crafted for legally authorized investigations. Headquartered in Petah Tikva, Israel, and established in 1999, the firm provides a comprehensive DI platform that enables…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Cellebrite DI stock: price history

16/10/25-39.1 %16/10/26

1D

-3.1%

1W

-2.0%

1M

-3.5%

6M

-16.3%

YTD

-38.8%

1Y

-39.1%

2Y

-39.3%

5Y

+6.4%

10Y

–

Next earnings date

Next earnings date

11/11/2026 (in 25 days)

Volatility around earnings

~88% stronger price swings than usual

Ask the agents about Cellebrite DI

Analyst assessment of Cellebrite DI

PRICE TARGET LOW

US$12.50

CONSENSUS

US$14.13

MEDIAN

US$14.50

PRICE TARGET HIGH

US$15.00

0

STRONG BUY

9

BUY

0

HOLD

0

SELL

0

STRONG SELL

9

TOTAL · Buy

As of: 15/09/2026

ANALYST FIRMRATINGACTIONDATE
DA DavidsonBuymaintain15/09/2026
Lake StreetBuymaintain14/08/2026
NeedhamBuymaintain14/08/2026
DA DavidsonBuymaintain14/08/2026
JP MorganOverweightmaintain14/08/2026
DA DavidsonBuymaintain06/08/2026
NeedhamBuymaintain15/05/2026
NeedhamBuymaintain12/02/2026

Cellebrite DI stock metrics

P/E

46.86

P/B

5.08

EV/EBITDA

23.36

RETURN ON EQUITY

1.2%

NET MARGIN

4.9%

DEBT/EQUITY

0.04

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

49.5%

FLOAT SHARES

123,459,080

AVG. DAILY VOLUME (30D)

2,559,915

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Utsumi Ryusuke

DirectorGrant15,190–Spontaneous29/09/2026

Domnitz Yonatan

DirectorGrant15,190–Spontaneous29/09/2026

CLAMMER ADAM

DirectorGrant15,190–Spontaneous28/09/2026

Ramji Shiven

OfficerGrant38,505–Spontaneous25/09/2026

Gruber Dafna

DirectorGrant15,190–Spontaneous17/09/2026
Page 1 / 5

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Harbour Capital Advisors, LLC0-22,45030/09/2026
MOODY NATIONAL BANK TRUST DIVISION0-60,69130/09/2026
True Wind Capital Management, L.P.13,861,007+030/06/2026
Voss Capital, LLC11,441,874+1,766,87430/06/2026
Pertento Partners LLP8,004,867+1,342,21330/06/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Cellebrite DI stock

What does Cellebrite DI do?

Cellebrite DI Ltd. is a company in the Technology sector, Software - Infrastructure industry, headquartered in Israel.

The CEO is Shiv Ramji, the company employs around 1,285 people.

The IPO was on 06/11/2020; the stock trades on NASDAQ under the ticker CLBT.

What do analysts say about Cellebrite DI stock?

9 analysts rate the stock, the consensus is Buy (as of 15/09/2026).

The average price target is US$14.13, ranging from US$12.50 to US$15.00, with a median of US$14.50.

This is an external assessment, not a statement by Market Jury.

When does Cellebrite DI report next?

The next earnings date is 11/11/2026.

Around past earnings, price swings were roughly 88% stronger than usual.

Does Cellebrite DI pay a dividend?

No, Cellebrite DI currently does not pay a dividend.

Which stocks are comparable to Cellebrite DI?

Comparable stocks include Microsoft, Palantir Technologies, Oracle, Palo Alto Networks, CrowdStrike Holdings, Fortinet, Cloudflare and Synopsys.

How can I get Cellebrite DI stock analyzed?

Clicking "Analyze stock" lets five strategies assess Cellebrite DI against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.